ZA200703558B - Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome - Google Patents

Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome

Info

Publication number
ZA200703558B
ZA200703558B ZA200703558A ZA200703558A ZA200703558B ZA 200703558 B ZA200703558 B ZA 200703558B ZA 200703558 A ZA200703558 A ZA 200703558A ZA 200703558 A ZA200703558 A ZA 200703558A ZA 200703558 B ZA200703558 B ZA 200703558B
Authority
ZA
South Africa
Prior art keywords
treatment
acid derivatives
metabolic syndrome
producing drugs
substituted cyclopropane
Prior art date
Application number
ZA200703558A
Inventor
Kadereit Dieter
Stengelin Siegfried
Heuer Hubert
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of ZA200703558B publication Critical patent/ZA200703558B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200703558A 2004-12-14 2007-05-03 Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome ZA200703558B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004060041A DE102004060041A1 (en) 2004-12-14 2004-12-14 Use of substituted cyclopropane acid derivative having dopamine receptor ligand activity to e.g. treat metabolic syndrome; reduce lipid in the plasma; lower free fatty acid in the plasma; and treat diabetic dyslipidemia

Publications (1)

Publication Number Publication Date
ZA200703558B true ZA200703558B (en) 2008-08-27

Family

ID=36580091

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200703558A ZA200703558B (en) 2004-12-14 2007-05-03 Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome

Country Status (3)

Country Link
CN (1) CN101068543A (en)
DE (1) DE102004060041A1 (en)
ZA (1) ZA200703558B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056889B2 (en) * 2002-12-16 2006-06-06 Kimberly-Clark, Worldwide, Inc. Compounds that bind P2Y2 or P2Y1 receptors

Also Published As

Publication number Publication date
CN101068543A (en) 2007-11-07
DE102004060041A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
IL181049A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL202515A (en) Thyroid-like compounds and their use for the preparation of medicaments for treatment of metabolic disorders
EP1937633B8 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
HK1171736A1 (en) Substituted acids for the treatment of respiratory diseases
ZA200805716B (en) Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
IL176913A0 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
IL189914A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them
IL190920A0 (en) Compounds for the treatment of metabolic disorders
HK1119070A1 (en) Use of trans-clomiphene in the manufacture of medicines
EP1744740A4 (en) Phenoxyalkycarboxylic acid derivatives in the treatment of inflammatory diseases
HK1100481A1 (en) Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorders in the depressed patient
IL199829A0 (en) Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
EP1731139A4 (en) S/o type pharmaceutical preparation and process for producing the same
EP1982724A4 (en) Therapeutic agent for metabolic syndrome and food containing the therapeutic agent
GB0410398D0 (en) The treatment of respiratory disease
EP1968559A4 (en) Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
EP1757282A4 (en) The use of kauranes compounds in the manufacture of medicament
EP1869004A4 (en) Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use
AP2656A (en) Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders
IL183464A0 (en) Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome
ZA200703558B (en) Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome
ZA201005394B (en) 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid y-lactone derivative,use thereof,and medicament containing said derivative
EP2047851A4 (en) Drug formulation containing fibrate medicament and process for producing the same
IL182406A0 (en) Use of an anti-atherothrombotic compound in obtaining medicaments intended for the treatment of vascular disorders
ZA200802948B (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease